Pro-Pharmaceuticals, Inc. Updates Clinical Trials Progress

NEWTON, Mass.--(BUSINESS WIRE)--Aug. 30, 2006--Pro-Pharmaceuticals, Inc. (Amex: PRW), a developer of novel carbohydrate therapeutic compounds, today updated its clinical trials progress.

MORE ON THIS TOPIC